MX2013005966A - Nuevos compuestos de benzofurano. - Google Patents
Nuevos compuestos de benzofurano.Info
- Publication number
- MX2013005966A MX2013005966A MX2013005966A MX2013005966A MX2013005966A MX 2013005966 A MX2013005966 A MX 2013005966A MX 2013005966 A MX2013005966 A MX 2013005966A MX 2013005966 A MX2013005966 A MX 2013005966A MX 2013005966 A MX2013005966 A MX 2013005966A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- novel
- concerned
- formula
- benzofurane compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Abstract
La presente invención se refiere a nuevos moduladores duales de los receptores 5-HT2A y D3 de fórmula (I) en donde n, x, Y, R1, R2, R3, y R4 son como se describen en la presente, así como también sales y ésteres de los mismos farmacéuticamente aceptables. Además la presente invención está relacionada con la manufactura de los compuestos de fórmula (I), composiciones farmacéuticas que los comprenden y su uso como medicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10195231 | 2010-12-15 | ||
PCT/EP2011/072403 WO2012080149A1 (en) | 2010-12-15 | 2011-12-12 | Novel benzofurane compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013005966A true MX2013005966A (es) | 2013-07-15 |
Family
ID=45218739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013005966A MX2013005966A (es) | 2010-12-15 | 2011-12-12 | Nuevos compuestos de benzofurano. |
Country Status (10)
Country | Link |
---|---|
US (1) | US8877778B2 (es) |
EP (1) | EP2651929A1 (es) |
JP (1) | JP2014503519A (es) |
KR (1) | KR20130126958A (es) |
CN (1) | CN103261190A (es) |
BR (1) | BR112013014770A2 (es) |
CA (1) | CA2819970A1 (es) |
MX (1) | MX2013005966A (es) |
RU (1) | RU2013132409A (es) |
WO (1) | WO2012080149A1 (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008280187B2 (en) * | 2007-07-26 | 2013-05-16 | F. Hoffmann-La Roche Ag | Dual modulators of 5-HT2A and D3 receptors |
CN106518841B (zh) * | 2015-09-15 | 2019-03-05 | 浙江京新药业股份有限公司 | 环己烷衍生物或其立体异构体或盐及其制备与应用 |
EP3495363B1 (en) | 2016-07-28 | 2023-08-23 | Shionogi & Co., Ltd | Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect |
CN111801330B (zh) | 2018-01-26 | 2024-04-05 | 盐野义制药株式会社 | 具有多巴胺d3受体拮抗作用的稠环化合物 |
WO2019146740A1 (ja) * | 2018-01-26 | 2019-08-01 | 塩野義製薬株式会社 | ドーパミンd3受容体拮抗作用を有する環式化合物 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5776963A (en) | 1989-05-19 | 1998-07-07 | Hoechst Marion Roussel, Inc. | 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility |
DK60693D0 (da) | 1993-05-26 | 1993-05-26 | Novo Nordisk As | Kemiske forbindelser, deres fremstilling og anvendelse |
DE4333254A1 (de) * | 1993-09-30 | 1995-04-06 | Merck Patent Gmbh | Piperidine und Piperazine |
CN1154105A (zh) * | 1994-06-08 | 1997-07-09 | H·隆德贝克有限公司 | 4-芳基-1-(二氢化茚甲基、二氢苯并呋喃甲基或二氢苯并噻吩甲基)哌啶、-四氢吡啶或哌嗪类化合物 |
DE69812980T2 (de) | 1997-02-07 | 2003-11-13 | Aventis Pharma Inc | (4-piperidinyl)-1h-2-benzopyran derivate verwendbar als antipsychotische mittel |
TW530054B (en) | 1997-09-24 | 2003-05-01 | Duphar Int Res | New piperazine and piperidine compounds |
WO1999040067A2 (en) | 1998-02-09 | 1999-08-12 | Duphar International Research B.V. | Benzisoxazole derivatives having d4-antagonistic activity |
GB0117577D0 (en) * | 2001-02-16 | 2001-09-12 | Aventis Pharm Prod Inc | Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands |
ATE412638T1 (de) | 2001-02-16 | 2008-11-15 | Aventis Pharma Inc | Heterocyclische substituierte carbonyl derivate und ihre verwendung als dopamin d3 rezeptor liganden |
GB0117950D0 (en) | 2001-02-16 | 2001-09-19 | Aventis Pharma Inc | Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands |
JP4497815B2 (ja) | 2001-02-16 | 2010-07-07 | アベンティス・ファーマスーティカルズ・インコーポレイテツド | 新規な複素環式アミド誘導体およびドーパミンd3受容体リガンドとしてのその使用 |
JP2006503106A (ja) | 2002-09-17 | 2006-01-26 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 統合失調症を処置するためのヘテロ環式置換ピペラジン |
CA2525866A1 (en) | 2003-05-16 | 2004-11-25 | Pfizer Products Inc. | Treatment of psychotic and depressive disorders |
BRPI0410419A (pt) | 2003-05-16 | 2006-05-30 | Pfizer Prod Inc | tratamento para a ansiedade com ziprasidona |
HUP0500170A3 (en) | 2005-02-03 | 2007-11-28 | Richter Gedeon Nyrt | Piperazine derivatives, process for producing them and pharmaceutical compositions containing them |
BRPI0707960A2 (pt) | 2006-02-17 | 2011-05-10 | Hoffmann La Roche | derivados de benzoil-piperidina como moduladores de 5ht2/d3, medicamento e uso dos mesmos |
EP1870405A1 (en) | 2006-06-22 | 2007-12-26 | Bioprojet | Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands |
AU2007316249B2 (en) | 2006-10-31 | 2013-01-24 | F. Hoffmann-La Roche Ag | Ether derivatives dual modulators of the 5-HT2A and D3 receptors |
AU2008280187B2 (en) * | 2007-07-26 | 2013-05-16 | F. Hoffmann-La Roche Ag | Dual modulators of 5-HT2A and D3 receptors |
AU2009294695B2 (en) | 2008-09-22 | 2012-09-13 | F. Hoffmann-La Roche Ag | Piperazine D3 and 5-HT2a receptor modulators |
JP2012502948A (ja) | 2008-09-23 | 2012-02-02 | エフ.ホフマン−ラ ロシュ アーゲー | ドーパミンd3受容体の調節剤として有用なイソオキサゾロ[4,5]ピリジン−3−イル−ピペラジン誘導体 |
JP2012502947A (ja) | 2008-09-23 | 2012-02-02 | エフ.ホフマン−ラ ロシュ アーゲー | ドーパミンD3受容体の調節剤として有用なベンゾ[d]イソオキサゾール−3−イル−ピペラジン誘導体 |
WO2010034648A1 (en) | 2008-09-23 | 2010-04-01 | F. Hoffmann-La Roche Ag | Pyridinylpiperazin derivatives useful as modulators of dopamine d3 receptors |
US8586579B2 (en) | 2010-06-21 | 2013-11-19 | Hoffmann-La Roche Inc. | Anellated pyridine compounds |
-
2011
- 2011-12-07 US US13/313,045 patent/US8877778B2/en not_active Expired - Fee Related
- 2011-12-12 KR KR1020137018138A patent/KR20130126958A/ko not_active Application Discontinuation
- 2011-12-12 CN CN2011800599332A patent/CN103261190A/zh active Pending
- 2011-12-12 RU RU2013132409/04A patent/RU2013132409A/ru not_active Application Discontinuation
- 2011-12-12 JP JP2013543674A patent/JP2014503519A/ja active Pending
- 2011-12-12 EP EP11793807.6A patent/EP2651929A1/en not_active Withdrawn
- 2011-12-12 MX MX2013005966A patent/MX2013005966A/es not_active Application Discontinuation
- 2011-12-12 CA CA2819970A patent/CA2819970A1/en not_active Abandoned
- 2011-12-12 WO PCT/EP2011/072403 patent/WO2012080149A1/en active Application Filing
- 2011-12-12 BR BR112013014770A patent/BR112013014770A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2012080149A1 (en) | 2012-06-21 |
EP2651929A1 (en) | 2013-10-23 |
US20120157449A1 (en) | 2012-06-21 |
BR112013014770A2 (pt) | 2016-10-04 |
CN103261190A (zh) | 2013-08-21 |
JP2014503519A (ja) | 2014-02-13 |
KR20130126958A (ko) | 2013-11-21 |
CA2819970A1 (en) | 2012-06-21 |
US8877778B2 (en) | 2014-11-04 |
RU2013132409A (ru) | 2015-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2014000626A (es) | Nuevos derivados de indol sustituidos como moduladores de gamma secretasa. | |
MX2014014229A (es) | Pirrolidina-2-carboxamidas sustituidas. | |
MX2011011484A (es) | Derivados de isoxazol-piridina como moduladores del acido gamma-aminobutirico. | |
PH12014501514A1 (en) | New azetidine derivatives, pharmaceutical compositions and uses thereof | |
MX363456B (es) | Compuestos para tratar atrofia muscular espinal. | |
IN2014MN02598A (es) | ||
MX347706B (es) | Derivados de triazol y su uso para trastornos neurologicos. | |
MX2012008259A (es) | Novedosos derivados biciclicos de triazol sustituidos como moduladores de gamma secretasa. | |
PH12014501542B1 (en) | Substituted pyrrolidine -2- carboxamides | |
EA201490320A1 (ru) | Соединения тетрагидропиридопиридина и тетрагидропиридопиримидина и их применение в качестве модуляторов рецептора c5a | |
IN2014CN04530A (es) | ||
MX2011007737A (es) | Derivados de hidroximetil isoxazol como moduladores de acido gamma-aminobutirico a. | |
EA201270216A1 (ru) | Фармацевтический состав | |
MY187718A (en) | Pharmaceutical formulations | |
EA201200471A1 (ru) | Простые эфирные производные бициклических гетероарилов | |
MX2011013884A (es) | Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas. | |
MX2011011303A (es) | Derivados de isoxazol. | |
BR112013000189A2 (pt) | compostos de piridina anelados | |
MA33948B1 (fr) | Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques. | |
EA201400854A1 (ru) | 4-(бензоимидазол-2-ил)тиазольные соединения и родственные аза производные | |
MX2013008531A (es) | Nuevos compuestos de benzodioxol-piperazina. | |
CA2891755C (en) | Substituted pyrido-piperazinone derivatives as gamma secretase modulators | |
TW200738627A (en) | Trialkylsilyl-indoles | |
MX2013005966A (es) | Nuevos compuestos de benzofurano. | |
WO2014062838A3 (en) | Pkm2 modulators and methods for their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |